ERLOCIP
- Erlotinib hydrochloride - (Tarceva)- @ -(May 2013)-Epidermal Growth Factor Receptor Inhibitors - Antineoplastic Agents
Compositions:
Erlotinib hydrochloride 150mg tablets,
List of Related Indications:
Erlotinib hydrochloride 150mg tablets,
- Metastatic Non-small cell lung carcinoma
Strength | Rate | Packing Style |
---|---|---|
150mg | 9900.00 | 30s tablets |